Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
60.7 USD | +0.56% | -1.94% | +9.25% |
May. 21 | Ani Pharmaceuticals Insider Sold Shares Worth $794,568, According to a Recent SEC Filing | MT |
May. 20 | ANI Pharmaceuticals Launches Kionex Suspension | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.25% | 1.17B | |
+38.61% | 728B | |
+32.32% | 603B | |
-4.72% | 360B | |
+20.23% | 332B | |
+1.98% | 279B | |
+15.81% | 244B | |
+8.01% | 207B | |
-5.36% | 205B | |
+6.08% | 164B |
- Stock Market
- Equities
- ANIP Stock
- News ANI Pharmaceuticals, Inc.
- Earnings Flash (ANIP) ANI PHARMACEUTICALS Reports Q1 Revenue $137.4M, vs. Street Est of $126M